Sanofi, GSK launch Phase III trial for their COVID-19 shot

Subscribe
Get in touch

Before you go we'd just like to ask you a quick question!

Your vote has been counted in the results below.

If you could vote on Brexit now which option would you choose?
Remain Leave

Sanofi, GSK launch Phase III trial for their COVID-19 shot

France's Sanofi (SASY.PA) and Britain's GlaxoSmithKline (GSK.L) on Thursday launched a late-stage human trial for their recombinant COVID-19 vaccine candidate that they hope to get approved by the end of this year.

Reuters on MSN.com - May 28, 2021

View the full story here: https://www.msn.com/en-gb/news/world/sanofi-gsk-launch-phase-iii-trial-for-their-covid-19-shot/ar-AAKqBRB

Contact Us

franklin@cccovid19.org
Our contact form
Curator login

Quick Links

Privacy policy
Terms & Conditions
Cookie Policies

Keep up to date with Connecting Communities for COVID19

Name*

Email*

Region*

Enter your region from the drop-down menu so we can tailor the news to you.

Privacy Policy | Terms & Conditions | Cookie Policies

Select or add an image to the Image library

Show only large

Search image library using the following tags

Cookie Notice - News Finder - corona_virus

We use cookies to enhance your visit to our site.
Read our Privacy policy, Cookie Policies and Terms & Conditions to find out more.